12 Health Care Stocks Moving In Monday's Pre-Market Session

Loading...
Loading...

Gainers

  • Clene CLNN stock increased by 51.9% to $2.05 during Monday's pre-market session. The company's market cap stands at $151.3 million.
  • Vallon Pharmaceuticals VLON shares moved upwards by 34.05% to $0.62. The market value of their outstanding shares is at $8.3 million.
  • Hillstream BioPharma HILS stock increased by 16.98% to $1.86. The market value of their outstanding shares is at $21.4 million.
  • Ocuphire Pharma OCUP stock moved upwards by 15.85% to $3.8. The market value of their outstanding shares is at $79.0 million.
  • Ocular Therapeutix OCUL stock rose 14.72% to $4.44. The market value of their outstanding shares is at $341.9 million.
  • Unity Biotechnology UBX shares increased by 13.43% to $4.98. The market value of their outstanding shares is at $70.6 million.

Losers

  • G1 Therapeutics GTHX stock fell 48.0% to $3.71 during Monday's pre-market session. The company's market cap stands at $187.7 million.
  • Sorrento Therapeutics SRNE shares decreased by 47.61% to $0.49. The company's market cap stands at $269.8 million.
  • Scilex Holding SCLX shares declined by 28.93% to $6.83. The market value of their outstanding shares is at $967.1 million.
  • Axsome Therapeutics AXSM shares decreased by 14.0% to $54.0. The market value of their outstanding shares is at $2.3 billion.
  • Creative Medical Tech CELZ stock declined by 11.62% to $0.76. The company's market cap stands at $10.6 million.
  • Citius Pharma CTXR shares decreased by 10.0% to $1.26. The company's market cap stands at $184.2 million. As per the press release, Q1 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...